DK1641488T3 - Epitopsammensætning til enterisk administrering fremstillet ved hydrolyse af antigenstrukturer med chymotrypsin - Google Patents

Epitopsammensætning til enterisk administrering fremstillet ved hydrolyse af antigenstrukturer med chymotrypsin

Info

Publication number
DK1641488T3
DK1641488T3 DK04740162.5T DK04740162T DK1641488T3 DK 1641488 T3 DK1641488 T3 DK 1641488T3 DK 04740162 T DK04740162 T DK 04740162T DK 1641488 T3 DK1641488 T3 DK 1641488T3
Authority
DK
Denmark
Prior art keywords
chymotrypsin
hydrolysis
enteric administration
administration prepared
epitope composition
Prior art date
Application number
DK04740162.5T
Other languages
English (en)
Inventor
Frederic Henot
Thierry Legon
Jean Duchateau
Original Assignee
Biotech Tools Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Tools Sa filed Critical Biotech Tools Sa
Priority claimed from PCT/EP2004/006733 external-priority patent/WO2004112833A1/en
Application granted granted Critical
Publication of DK1641488T3 publication Critical patent/DK1641488T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Lead Frames For Integrated Circuits (AREA)
DK04740162.5T 2003-06-23 2004-06-22 Epitopsammensætning til enterisk administrering fremstillet ved hydrolyse af antigenstrukturer med chymotrypsin DK1641488T3 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP03014020 2003-06-23
US53062903P 2003-12-19 2003-12-19
EP03029356 2003-12-19
PCT/EP2004/006733 WO2004112833A1 (en) 2003-06-23 2004-06-22 Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin

Publications (1)

Publication Number Publication Date
DK1641488T3 true DK1641488T3 (da) 2011-07-18

Family

ID=43825131

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04740162.5T DK1641488T3 (da) 2003-06-23 2004-06-22 Epitopsammensætning til enterisk administrering fremstillet ved hydrolyse af antigenstrukturer med chymotrypsin

Country Status (4)

Country Link
US (2) US20070292446A9 (da)
AT (1) ATE503494T1 (da)
DE (1) DE602004032025D1 (da)
DK (1) DK1641488T3 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166286B2 (en) 2015-02-20 2019-01-01 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10143742B2 (en) 2015-02-20 2018-12-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US11452774B2 (en) 2015-02-20 2022-09-27 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10149904B2 (en) 2015-02-20 2018-12-11 The Board Of Trusteees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
US10064936B2 (en) 2015-02-20 2018-09-04 The Board Of Trustees Of The Leland Stanford Junior University Mixed allergen compositions and methods for using the same
CA3069967A1 (en) 2017-07-18 2019-01-24 Before Brands, Inc. Methods for making mixed allergen compositions
WO2020154476A1 (en) 2019-01-23 2020-07-30 Before Brands, Inc. Methods for making mixed allergen compositions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215036A (en) * 1978-08-15 1980-07-29 Research Corporation Modified grass pollen antigens
US5898037A (en) * 1992-11-13 1999-04-27 Marx; Alvin J. Formulations of magnesium compounds for local application and methods of treatment using the same
JP3818680B2 (ja) * 1994-05-12 2006-09-06 サントリー株式会社 アレルギー症状の予防又は改善剤
SE9402089D0 (sv) * 1994-06-14 1994-06-14 Rudolf Valenta Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules, diagnostic and therapeutic uses of said allergens and fragments
BE1011033A6 (fr) * 1997-03-05 1999-04-06 Univ Bruxelles Composition pharmaceutique et/ou alimentaire pour le traitement de pathologies liees a un rejet de greffe, une reaction allergique ou auto-immune ou du cancer.
ATE353669T1 (de) * 2000-12-28 2007-03-15 Biomay Prod & Handel Allergievakzine sowie ihre herstellung
US6319679B1 (en) * 2001-01-26 2001-11-20 Board Of Regents, The University Of Texas System PAS kinase

Also Published As

Publication number Publication date
US20060147459A1 (en) 2006-07-06
US20150150956A1 (en) 2015-06-04
ATE503494T1 (de) 2011-04-15
DE602004032025D1 (de) 2011-05-12
US20070292446A9 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
CY2013036I2 (el) Συνθεσεις εμβολιου κατα της ναϊσσερια, που περιεχουν εναν συνδυασμο αντιγονων
DK1406656T3 (da) Fremgangsmåder til administrering af anti-TNF-alfa-antistoffer
MA29406B1 (fr) Vaccin toxoide alpha de c. perfringens
EA200800812A1 (ru) Композиции антитела против cd3
ATE527281T1 (de) Impfstoffe gegen aids umfassend cmv/r nucleinsäurekonstrukte
EA200700904A1 (ru) Вакцины против вируса японского энцефалита и вируса западного нила
EA200802170A1 (ru) Лиофилизированная композиция терапевтического пептидного антитела
EA200801798A1 (ru) Виросомоподобные везикулы, содержащие антигены, производные от gp41
WO2006110831A3 (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
DK1957656T3 (da) Fermentativ fremstilling af lysin
DK1656372T3 (da) 2,4-pyrimidindiaminforbindelser til anvendelse til behandling eller forebyggelse af autoimmunsygdomme
MA30345B1 (fr) Formulation d'anticorps monoclonal humain anti-igf-1r
DK1557462T3 (da) Transplantataccept-inducerende celler af monocytisk oprindelse, deres fremstilling og anvendelse
CR11307A (es) Vacunas
EA200801109A1 (ru) Состав для литья и способ его получения
NO20074885L (no) N-proteinmutanter av porcinreproduktive og andedrettssyndromvirus
WO2005111079A3 (en) Hiv vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-hiv-1 antibodies against the membrane proximal domain of hiv gp41
NL1022322A1 (nl) Actuator voor een optische aftaster.
DK1641488T3 (da) Epitopsammensætning til enterisk administrering fremstillet ved hydrolyse af antigenstrukturer med chymotrypsin
EA200800601A1 (ru) Связывающие fas антитела
DK1817326T3 (da) Industriel fremgangsmåde til fremstilling af 17-hydroxy-6-beta, 7-beta, 15-beta, 16-beta-bismethylen-3-oxo-17-alpha-pregn-4-en-21-carboxylsyre-gamma-lacton og nøglemellemprodukter for denne fremgangsmåde
DK1784497T3 (da) Fremgangsmåde til fremstilling af mycophenolatmofetil ved enzymatisk transesterificering
CL2010001175A1 (es) Composicion de vacuna que comprende un antigeno de proteina viral 2 (vp-2) del virus causante de la enfermedad de la bursitis infecciosa (ibdv).
WO2007026078A3 (fr) Epitopes t cd4+ des antigenes mage-a restreints a hla-dp4 et leurs applications
WO2002026785A3 (de) Cd4+ t-lymphozyten spezifische hepatitis c virus-epitope